Concentra Group Declares $0.0625 Quarterly Dividend
Concentra Group Holdings Parent, Inc. (NYSE: CON), the nation's largest provider of occupational health services by number of locations, declared a cash dividend of $0.0625 per share. The board approved the dividend on February 25, 2026.
Concentra Group Holdings Parent, Inc. (NYSE: CON), the nation's largest provider of occupational health services by number of locations, declared a cash dividend of $0.0625 per share. The board of directors approved the distribution on February 25, 2026. Read more dividend announcements.
Shareholders of record as of the close of business on March 12, 2026 will receive payment on or about March 19, 2026. The company noted that future dividend declarations remain at the discretion of the board after considering the company's financial condition, operating results, and debt obligations.
| Dividend Details | Date |
|---|---|
| Amount Per Share | $0.0625 |
| Declaration Date | February 25, 2026 |
| Record Date | March 12, 2026 |
| Payment Date | March 19, 2026 |
| Frequency | Quarterly |
Fourth Quarter and Full Year 2025 Performance
The dividend announcement accompanied Concentra's fourth quarter and full year 2025 results, released February 26, 2026. Fourth quarter revenue reached $539.1 million, up 15.9% from $465.0 million in the prior year period. Operating cash flow for the quarter totaled $118.7 million compared to $93.7 million a year earlier.
For the full year ended December 31, 2025, Concentra reported revenue of $2.16 billion, a 13.9% increase from $1.90 billion in 2024. Adjusted EBITDA rose 14.6% to $431.9 million with a margin of 20.0%, up 13 basis points year-over-year. Net income reached $172.8 million, essentially flat compared to $171.9 million in the prior year.
The company's balance sheet showed cash of $79.9 million and total debt of $1.57 billion as of December 31, 2025. Net leverage stood at 3.4 times, in compliance with credit agreement covenants.
Capital Allocation
During the fourth quarter, Concentra used $68.6 million in financing activities, including $38.9 million in debt repayments, $22.4 million in share repurchases, and $8.0 million in dividend payments. Capital expenditures for the quarter were $20.2 million, including $4.0 million in one-time costs related to the integration of Nova Medical Centers.
The company has a $100 million share repurchase program authorized by the board. Free cash flow totaled $98.6 million in the fourth quarter, up from $77.0 million in the same period last year.
2026 Guidance
Concentra issued full year 2026 guidance projecting revenue of $2.25 billion to $2.35 billion and adjusted EBITDA of $450 million to $470 million. The company expects to achieve a net leverage ratio of 3.0 times or below, with free cash flow of $200 million to $225 million. Capital expenditures are forecast at $70 million to $80 million.